855 studies found for:    Open Studies | "Carcinoma, Bronchogenic"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Carcinoma, Bronchogenic"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Unknown  Efficacy and Safety Study of Gefitinib in Squamous NSCLC Patients Who Failed First-Line Chemotherapy
Condition: Squamous Cell Carcinoma of Bronchus
Intervention: Drug: Gefitinib
2 Unknown  Study to Determine the Efficacy of Bendamustin in Patients With Recurrent Small Cell Lung Cancer (SCLC)
Condition: Recurrent Small Cell Lung Cancer
Intervention: Drug: Bendamustin/Ribomustin
3 Recruiting Phase I Trial of Afatinib (BIBW 2992) and Dasatinib in Non-small Cell Lung Cancer (NSCLC)
Conditions: Lung Cancer;   Non-small Cell Lung Cancer (NSCLC)
Interventions: Drug: Dasatinib - 1A;   Drug: Afatinib - 1A;   Drug: Dasatinib - 1B;   Drug: Afatinib - 1B
4 Not yet recruiting An Oral Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor, AZD3759, in Patients Who Have Advanced Non-Small Cell Lung Cancer
Condition: EGFR Mutation Positive Advanced Non Small Cell Lung Cancer
Intervention: Drug: AZD3759
5 Unknown  Biomarkers in Blood Samples From Patients With Refractory Non-Small Cell Lung Cancer Previously Treated With Sorafenib Tosylate
Condition: Lung Cancer
Interventions: Genetic: DNA analysis;   Genetic: mutation analysis;   Other: laboratory biomarker analysis
6 Recruiting Induction Chemotherapy Followed by CCRT According to EGFR Mutation Status in NSCLC III
Conditions: Lung Cancer;   NSCLC
Interventions: Drug: Erlotinib;   Drug: Induction or consolidation IP chemotherapy;   Drug: CCRT with IP chemotherapy (Irinotecan + Cisplatin);   Radiation: CCRT
7 Recruiting Stage IIIB/IV Non-Small Cell Lung Cancer
Condition: Non Small Cell Lung Cancer
Intervention: Drug: Pazopanib plus Paclitaxel
8 Recruiting Maintenance Low Dose Oral Navelbine In Patients With Non Small Cell Lung Cancer - MA.NI.LA Trial
Conditions: Non-small Cell Lung Cancer Stage IIIB;   Non-small Cell Lung Cancer Stage IV
Intervention: Drug: Vinorelbine
9 Recruiting Topotecan Hydrochloride or Cyclodextrin-Based Polymer-Camptothecin CRLX101 in Treating Patients With Recurrent Small Cell Lung Cancer
Conditions: Extensive Stage Small Cell Lung Cancer;   Recurrent Small Cell Lung Cancer
Interventions: Drug: topotecan hydrochloride;   Drug: cyclodextrin-based polymer-camptothecin CRLX101
10 Recruiting A Study Of PF-06263507 In Patients With Advanced Solid Tumors
Conditions: Neoplasms;   Carcinoma, Non Small Cell Lung;   Breast Neoplasms;   Ovarian Neoplasms
Intervention: Drug: PF-06263507
11 Recruiting Gefitinib With or Without Pemetrexed/Cisplatin in Brain Metastases From Non-small Cell Lung Cancer
Conditions: Non-small Cell Lung Cancer;   Brain Metastases;   EGFR
Interventions: Drug: Gefitinib and Pemetrexed/cisplatin;   Drug: Gefitinib mono-therapy
12 Recruiting Clinical Trial on the Prevention of Thrombocytopenia After First-line Chemotherapy
Condition: Carcinoma, Non-Small-Cell Lung
Intervention: Drug: recombinant human thrombopoietin
13 Recruiting Nitroglycerin in Non-small Cell Lung Cancer
Condition: Non Small Cell Lung Cancer (NSCLC)
Intervention: Drug: Nitroglycerin patch
14 Unknown  Detection of Early Lung Cancer by Serum Protein Expression Profiling
Condition: Non-small Cell Lung Cancer
Intervention:
15 Recruiting Gene Expression Levels in Predicting Treatment Response in Patients With Stage IV Non-small Cell Lung Cancer
Conditions: Recurrent Non-small Cell Lung Cancer;   Stage IV Non-small Cell Lung Cancer
Interventions: Drug: docetaxel;   Drug: pemetrexed disodium;   Drug: gemcitabine hydrochloride;   Other: laboratory biomarker analysis
16 Unknown  Lung Cancer Rehabilitation Study
Condition: Non Small Cell Lung Cancer
Interventions: Other: Rehabilitation;   Other: Usual care
17 Recruiting A Study of TS-1 Plus Cisplatin in Patients With Advanced Non-small-cell Lung Cancer
Condition: Non-small-cell Lung Cancer (NSCLC)
Intervention: Drug: TS-1/Cisplatin
18 Recruiting Immunotherapy Study in Progressive or Relapsed Non-Small Cell Lung Cancer
Conditions: Non-small Cell Lung Cancer;   Progression of Non-small Cell Lung Cancer;   Non-small Cell Lung Cancer Recurrent
Interventions: Drug: Docetaxel;   Biological: HyperAcute®-Lung Immunotherapy;   Drug: Gemcitabine;   Drug: Pemetrexed
19 Recruiting Value of Physical Capacity Tests in Lung Cancer
Conditions: Non Small Cell Lung Cancer;   Small Cell Lung Cancer
Intervention:
20 Recruiting Concomitant Radio-chemotherapy in the Elderly
Condition: Non Small Cell Lung Cancer
Interventions: Drug: Cisplatin IV;   Drug: Vinorelbine;   Radiation: Radiotherapy

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years